Trial · NCT01226706
Registered outcomes39
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 39
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Maximum Capacity at Cystoscopy Between Baseline and 6 Month Follow-up | Baseline to 6 months | Cystoscopy is a test performed with a cystoscope, a narrow tube with a tiny camera at its tip, inserted into the urethra and bladder to see the inside of the bladder and urethra. Maximum bladder capacity--the amount of liquid or gas the bladder can hold under anesthesia. Without anesthesia, capacity is limited by either pain or a severe urge to urinate. |
| Secondary | Change in Incontinence Episodes Between Baseline and 6 Week Follow-up | Baseline to 6 weeks | Incontinence- involuntary leakage of urine |
| Secondary | Change in Incontinence Episodes Between Baseline and 3 Month Follow-up | Baseline to 3 month | Incontinence- involuntary leakage of urine |
| Secondary | Change in Incontinence Episodes Between Baseline and 6 Month Follow-up | Baseline to 6 month | Incontinence- involuntary leakage of urine |
| Secondary | Change in Incontinence Episodes Between Baseline and 9 Month Follow-up | Baseline to 9 months | Incontinence- involuntary leakage of urine |
| Secondary | Change in Incontinence Episodes Between Baseline and 12 Month Follow-up | Baseline and 12 months | Incontinence- involuntary leakage of urine |
| Secondary | Change in Incontinence Episodes Between Baseline and 24 Months Follow-up | Baseline and 24 months | Incontinence- involuntary leakage of urine |
| Secondary | Change in Number of Daytime Voids Between Baseline and 6 Week Follow-up | Baseline to 6 weeks | Frequency of daily urination |
| Secondary | Change in Number of Daytime Voids Between Baseline and 3 Month Follow-up | Baseline to 3 month | Frequency of daily urination |
| Secondary | Change in Number of Daytime Voids Between Baseline and 6 Month Follow-up | Baseline to 6 months | Frequency of daily urination |
| Secondary | Change in Number of Daytime Voids Between Baseline and 9 Month Follow-up | Baseline to 9 months | Frequency of daily urination |
| Secondary | Change in Number of Daytime Voids Between Baseline and 12 Month Follow-up | Baseline to 12 months | Frequency of daily urination |
| Secondary | Change in Number of Daytime Voids Between Baseline and 24 Month Follow-up | Baseline to 24 months | Frequency of daily urination |
| Secondary | Change in Number of Night Voids Between Baseline and 6 Week Follow-up | Baseline to 6 weeks | Frequency of night voiding |
| Secondary | Change in Number of Night Voids Between Baseline and 3 Month Follow-up | Baseline to 3 months | Frequency of night voiding |
| Secondary | Change in Number of Night Voids Between Baseline and 6 Month Follow-up | Baseline to 6 months | Frequency of night voiding |
| Secondary | Change in Number of Night Voids Between Baseline and 9 Month Follow-up | Baseline and 9 months | Frequency of night voiding |
| Secondary | Change in Number of Night Voids Between Baseline and 12 Month Follow-up | Baseline to 12 months | Frequency of night voiding |
| Secondary | Change in Number of Night Voids Between Baseline and 24 Months Follow-up | Baseline and 24 months | Frequency of night voiding |
| Secondary | Subjective Benefit Assessment at 6 Weeks | Baseline to 6 weeks | Self assessed description of how well they believed the Botulinum Toxin type A was working. The patients' subjective assessment of the treatment's efficacy was obtained verbally using a four-point rating scale. Rating options were: 1. dry (complete response), 2. improvement (\> 50% reduction in incontinence), 3. partial response (≤ 50% reduction in incontinence), 4. no response to treatment. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01226706/registered